Myles David C., Chief Discovery and Non-Clinical Development Officer at Olema Pharmaceuticals ($OLMA), sold shares on the open market eight times over the past year, totaling about $4.7 million. His most recent sale occurred on January 14, 2026. These transactions rank him 2039th among 11,678 insiders by sale value, below the average of $8.6 million per seller and 6.4 trades. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | A | Performance Stock Options (Right to Buy) | 106250 | $0.00 | 106,250.0000 | 85,732,221 | 9999.99% | 0.12% |
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 85,732,221 | 9999.99% | 0.29% |
| Jan. 13, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | M | Stock Option (Right to Buy) | 50000 | $0.00 | 100,000.0000 | 85,732,221 | 33.33% | 0.06% |
| Jan. 14, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 35003 | $28.99 | 700,438.0000 | 85,732,221 | 4.76% | 0.04% |
| Jan. 14, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 14997 | $28.60 | 735,441.0000 | 85,732,221 | 2.00% | 0.02% |
| Jan. 14, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | M | Common Stock | 50000 | $4.87 | 750,438.0000 | 85,732,221 | 7.14% | 0.06% |
| Jan. 13, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 200 | $28.49 | 700,438.0000 | 85,732,221 | 0.03% | 0.00% |
| Jan. 13, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 49800 | $27.60 | 700,638.0000 | 85,732,221 | 6.64% | 0.06% |
| Jan. 12, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 10000 | $28.34 | 700,438.0000 | 85,732,221 | 1.41% | 0.01% |
| Jan. 13, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | M | Common Stock | 50000 | $4.87 | 750,438.0000 | 85,732,221 | 7.14% | 0.06% |
| Jan. 14, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | M | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 85,732,221 | 50.00% | 0.06% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 43729 | $30.40 | 725,604.0000 | 85,732,221 | 5.68% | 0.05% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | G | Common Stock | 9000 | $0.00 | 710,558.0000 | 85,732,221 | 1.25% | 0.01% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 6046 | $31.39 | 719,558.0000 | 85,732,221 | 0.83% | 0.01% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 1225 | $28.08 | 769,333.0000 | 85,732,221 | 0.16% | 0.00% |
| Feb. 28, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | A | Stock Option (Right to Buy) | 205000 | $0.00 | 205,000.0000 | 58,743,522 | 9999.99% | 0.35% |
| Dec. 9, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | A | Common Stock | 48750 | $0.00 | 792,076.0000 | 57,262,803 | 6.56% | 0.09% |
| Dec. 10, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 12452 | $9.38 | 779,624.0000 | 57,262,803 | 1.57% | 0.02% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 13314 | $8.66 | 766,310.0000 | 57,262,803 | 1.71% | 0.02% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 300 | $9.39 | 766,010.0000 | 57,262,803 | 0.04% | 0.00% |
| Feb. 1, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 45,247,098 | 9999.99% | 0.43% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 200 | $15.32 | 748,429.0000 | 0 | 0.03% | 0.00% |
| Nov. 22, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 6653 | $13.89 | 741,776.0000 | 0 | 0.89% | 0.00% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 6776 | $14.87 | 748,629.0000 | 0 | 0.90% | 0.00% |
| Nov. 20, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | A | Common Stock | 26250 | $0.00 | 755,405.0000 | 0 | 3.60% | 0.00% |
| Nov. 8, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 200 | $17.61 | 728,947.0000 | 0 | 0.03% | 0.00% |
| Nov. 1, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 6668 | $15.02 | 733,020.0000 | 0 | 0.90% | 0.00% |
| Nov. 2, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 3332 | $15.36 | 729,688.0000 | 0 | 0.45% | 0.00% |
| Nov. 3, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 541 | $17.51 | 729,147.0000 | 0 | 0.07% | 0.00% |
| Sept. 19, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | S | Common Stock | 20000 | $12.67 | 739,688.0000 | 0 | 2.63% | 0.00% |
| Feb. 1, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Myles David C. | Chief Development Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |